Apyx Medical Corp (APYX) Free cash flow
- Free cash flow · 12 months (USD): Value $-11.05M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value -18.91%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $-11.05M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $-10.13M − $920.00K ≈ $-11.05M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | -18.91% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $-11.05M ÷ $58.41M × 100 ≈ -18.91% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-10.13M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 1.17× | Operating cash flow / net income. Period ending 2026-06-30. $-10.13M ÷ $-8.63M ≈ 1.17× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -10.13M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 920.00K USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | -11.05M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 58.41M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -8.63M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $-11.05M | (m) | $-10.13M | $920.00K | (m) | $58.41M | (m) | $-8.63M | (m) | (m) | -18.91% | 1.17× |
| 2026-03-31 | $-8.99M | (m) | $-7.87M | $1.12M | (m) | $55.90M | (m) | $-9.17M | (m) | (m) | -16.08% | 0.86× |
| 2025-12-31 | $-9.12M | (m) | $-8.00M | $1.11M | (m) | $52.84M | (m) | $-11.21M | (m) | (m) | -17.25% | 0.71× |
| 2025-09-30 | $-9.49M | (m) | $-8.41M | $1.08M | (m) | $47.90M | (m) | $-14.54M | (m) | (m) | -19.82% | 0.58× |
| 2025-06-30 | $-10.03M | (m) | $-9.31M | $718.00K | (m) | $46.51M | (m) | $-17.26M | (m) | (m) | -21.56% | 0.54× |
| 2025-03-31 | $-13.15M | (m) | $-12.41M | $742.00K | (m) | $47.29M | (m) | $-20.04M | (m) | (m) | -27.81% | 0.62× |
| 2024-12-31 | $-18.77M | (m) | $-18.05M | $722.00K | (m) | $48.10M | (m) | $-23.46M | (m) | (m) | -39.02% | 0.77× |
| 2024-09-30 | $-17.89M | (m) | $-17.32M | $570.00K | (m) | $48.54M | (m) | $-28.44M | (m) | (m) | -36.86% | 0.61× |
| 2024-06-30 | $-9.78M | (m) | $-9.19M | $591.00K | (m) | $49.03M | (m) | $-28.37M | (m) | (m) | -19.94% | 0.32× |
| 2024-03-31 | $-10.17M | (m) | $-9.71M | $458.00K | (m) | $50.45M | (m) | $-22.81M | (m) | (m) | -20.15% | 0.43× |
| 2023-12-31 | $-5.78M | (m) | $-5.25M | $533.00K | (m) | $52.35M | (m) | $-18.71M | (m) | (m) | -11.05% | 0.28× |
| 2023-09-30 | $-8.17M | (m) | $-7.59M | $582.00K | (m) | $50.30M | (m) | $-15.15M | (m) | (m) | -16.24% | 0.50× |
| 2023-06-30 | $-17.24M | (m) | $-16.64M | $596.00K | (m) | $47.44M | (m) | $-16.29M | (m) | (m) | -36.34% | 1.02× |
| 2023-03-31 | $-18.50M | (m) | $-17.66M | $841.00K | (m) | $44.16M | (m) | $-20.72M | (m) | (m) | -41.90% | 0.85× |
| 2022-12-31 | $-21.29M | (m) | $-20.28M | $1.01M | (m) | $44.51M | (m) | $-23.18M | (m) | (m) | -47.83% | 0.87× |
| 2022-09-30 | $-16.74M | (m) | $-15.54M | $1.20M | (m) | $48.72M | (m) | $-19.14M | (m) | (m) | -34.35% | 0.81× |
| 2022-06-30 | $-14.96M | (m) | $-13.78M | $1.18M | (m) | $51.44M | (m) | $-17.60M | (m) | (m) | -29.09% | 0.78× |
| 2022-03-31 | $-13.72M | (m) | $-12.91M | $810.00K | (m) | $52.37M | (m) | $-16.22M | (m) | (m) | -26.21% | 0.80× |
| 2021-12-31 | $-11.17M | (m) | $-10.45M | $723.00K | (m) | $48.52M | (m) | $-15.17M | (m) | (m) | -23.03% | 0.69× |
| 2021-09-30 | $-12.46M | (m) | $-11.68M | $779.00K | (m) | $43.16M | (m) | $-14.70M | (m) | (m) | -28.87% | 0.79× |
| 2021-06-30 | $-11.31M | (m) | $-10.69M | $618.00K | (m) | $38.28M | (m) | $-14.20M | (m) | (m) | -29.54% | 0.75× |
| 2021-03-31 | $-11.39M | (m) | $-10.71M | $683.00K | (m) | $31.35M | (m) | $-14.85M | (m) | (m) | -36.34% | 0.72× |
| 2020-12-31 | $-16.65M | (m) | $-16.07M | $581.00K | (m) | $27.71M | (m) | $-11.90M | (m) | (m) | -60.07% | 1.35× |
| 2020-09-30 | $-18.72M | (m) | $-18.30M | $418.00K | (m) | $24.63M | (m) | $-15.80M | (m) | (m) | -76.00% | 1.16× |
| 2020-06-30 | $-21.20M | (m) | $-20.23M | $967.00K | (m) | $25.25M | (m) | (m) | (m) | (m) | -83.96% | (m) |
| 2020-03-31 | $-22.07M | (m) | $-20.79M | $1.27M | (m) | $27.60M | (m) | (m) | (m) | (m) | -79.94% | (m) |
| 2019-12-31 | $-19.78M | (m) | $-18.48M | $1.30M | (m) | $28.23M | (m) | $-19.71M | (m) | (m) | -70.04% | 0.94× |
| 2019-09-30 | $-34.51M | (m) | $-33.27M | $1.24M | (m) | $25.70M | (m) | $-17.23M | (m) | (m) | -134.28% | 1.93× |
| 2019-06-30 | $-30.42M | (m) | $-29.47M | $953.00K | (m) | $21.99M | (m) | $-12.78M | (m) | (m) | -138.36% | 2.31× |
| 2019-03-31 | $-25.20M | (m) | $-24.54M | $661.00K | (m) | $19.11M | (m) | $-11.38M | (m) | (m) | -131.87% | 2.16× |
| 2018-12-31 | $-21.37M | (m) | $-21.01M | $363.00K | (m) | $16.69M | (m) | $-9.49M | (m) | (m) | -128.10% | 2.21× |
| 2018-09-30 | $-2.50M | (m) | $-2.10M | $396.00K | (m) | $43.07M | (m) | $-520.00K | (m) | (m) | -5.80% | 4.05× |
| 2018-06-30 | $-2.30M | (m) | $-1.49M | $805.00K | (m) | $42.09M | (m) | $-3.28M | (m) | (m) | -5.46% | 0.46× |
| 2018-03-31 | $-2.69M | (m) | $-1.99M | $692.00K | (m) | $40.41M | (m) | $-4.31M | (m) | (m) | -6.65% | 0.46× |
| 2017-12-31 | $-4.33M | (m) | $-3.70M | $624.00K | (m) | $38.88M | (m) | $-5.06M | (m) | (m) | -11.13% | 0.73× |
| 2017-09-30 | $-5.51M | (m) | $-4.98M | $535.00K | (m) | $37.03M | (m) | $-4.76M | (m) | (m) | -14.89% | 1.05× |
| 2017-06-30 | $-4.75M | (m) | $-4.35M | $396.00K | (m) | $37.74M | (m) | $-4.48M | (m) | (m) | -12.58% | 0.97× |
| 2017-03-31 | $-3.72M | (m) | $-3.39M | $336.00K | (m) | $37.24M | (m) | $-3.69M | (m) | (m) | -10.00% | 0.92× |
| 2016-12-31 | $-3.12M | (m) | $-2.84M | $286.00K | (m) | $36.63M | (m) | $-3.95M | (m) | (m) | -8.53% | 0.72× |
| 2016-09-30 | $-3.31M | (m) | $-3.31M | $-1.00K | (m) | $35.43M | (m) | $-4.83M | (m) | (m) | -9.35% | 0.69× |
| 2016-06-30 | $-4.04M | (m) | $-4.04M | $0.00 | (m) | $33.19M | (m) | $-5.46M | (m) | (m) | -12.19% | 0.74× |
| 2016-03-31 | $-6.45M | (m) | $-6.26M | $188.00K | (m) | $31.17M | (m) | $-6.44M | (m) | (m) | -20.69% | 0.97× |
| 2015-12-31 | $-6.21M | (m) | $-5.79M | $421.00K | (m) | $29.52M | (m) | $-5.37M | (m) | (m) | -21.03% | 1.08× |
| 2015-09-30 | $-5.48M | (m) | $-4.57M | $915.00K | (m) | $28.69M | (m) | $-9.15M | (m) | (m) | -19.11% | 0.50× |
| 2015-06-30 | $-4.15M | (m) | $-3.23M | $928.00K | (m) | $27.66M | (m) | $-10.30M | (m) | (m) | -15.02% | 0.31× |
| 2015-03-31 | $-1.97M | (m) | $-1.16M | $809.00K | (m) | $27.33M | (m) | $-8.55M | (m) | (m) | -7.20% | 0.14× |
| 2014-12-31 | $-1.05M | (m) | $-417.00K | $630.00K | (m) | $27.68M | (m) | $-17.28M | (m) | (m) | -3.78% | 0.02× |
| 2014-09-30 | $-2.45M | (m) | $-1.96M | $490.00K | (m) | $26.34M | (m) | $-14.56M | (m) | (m) | -9.31% | 0.13× |
| 2014-06-30 | $-3.04M | (m) | $-2.58M | $459.00K | (m) | $25.35M | (m) | $-12.17M | (m) | (m) | -12.00% | 0.21× |
| 2014-03-31 | $-3.86M | (m) | $-3.33M | $532.00K | (m) | $24.45M | (m) | $-13.54M | (m) | (m) | -15.81% | 0.25× |
| 2013-12-31 | $-3.12M | (m) | $-2.54M | $588.00K | (m) | $23.66M | (m) | $-4.34M | (m) | (m) | -13.20% | 0.58× |
| 2013-09-30 | $-1.90M | (m) | $-1.18M | $721.00K | (m) | $24.36M | (m) | $-1.58M | (m) | (m) | -7.80% | 0.74× |
| 2013-06-30 | $-2.31M | (m) | $-1.56M | $759.00K | (m) | $25.24M | (m) | $-1.25M | (m) | (m) | -9.17% | 1.24× |
| 2013-03-31 | $-243.00K | (m) | $398.00K | $641.00K | (m) | $26.63M | (m) | $21.00K | (m) | (m) | -0.91% | 18.95× |
| 2012-12-31 | $-588.00K | (m) | $165.00K | $753.00K | (m) | $27.67M | (m) | $617.00K | (m) | (m) | -2.12% | 0.27× |
| 2012-09-30 | $-626.00K | (m) | $-94.00K | $532.00K | (m) | $27.00M | (m) | $-544.00K | (m) | (m) | -2.32% | 0.17× |
| 2012-06-30 | $-434.00K | (m) | $134.00K | $568.00K | (m) | $26.59M | (m) | $-473.00K | (m) | (m) | -1.63% | -0.28× |
| 2012-03-31 | $-36.00K | (m) | $674.00K | $710.00K | (m) | $25.99M | (m) | $-196.00K | (m) | (m) | -0.14% | -3.44× |
| 2011-12-31 | $1.35M | (m) | $1.90M | $542.00K | (m) | $25.41M | (m) | $109.00K | (m) | (m) | 5.33% | 17.40× |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-385.00K | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-444.00K | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-727.00K | (m) | $-526.00K | $201.00K | (m) | $24.23M | (m) | $-1.53M | (m) | (m) | -3.00% | 0.34× |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-2.56M | (m) | $-97.00K | $2.46M | (m) | $26.95M | (m) | $596.00K | (m) | (m) | -9.51% | -0.16× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |